Does DUPILUMAB Cause Therapeutic product effect delayed? 90 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 90 reports of Therapeutic product effect delayed have been filed in association with DUPILUMAB (Dupixent). This represents 0.0% of all adverse event reports for DUPILUMAB.
90
Reports of Therapeutic product effect delayed with DUPILUMAB
0.0%
of all DUPILUMAB reports
2
Deaths
6
Hospitalizations
How Dangerous Is Therapeutic product effect delayed From DUPILUMAB?
Of the 90 reports, 2 (2.2%) resulted in death, 6 (6.7%) required hospitalization.
Is Therapeutic product effect delayed Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DUPILUMAB. However, 90 reports have been filed with the FAERS database.
What Other Side Effects Does DUPILUMAB Cause?
Pruritus (44,279)
Dermatitis atopic (33,670)
Product use in unapproved indication (33,452)
Rash (30,895)
Injection site pain (27,799)
Drug ineffective (23,712)
Dry skin (20,239)
Eczema (20,020)
Product dose omission issue (18,189)
Condition aggravated (16,459)
What Other Drugs Cause Therapeutic product effect delayed?
ADALIMUMAB (244)
TOFACITINIB (178)
CARBIDOPA\LEVODOPA (168)
SECUKINUMAB (162)
POLYETHYLENE GLYCOL 3350 (125)
RIMEGEPANT (120)
TASIMELTEON (93)
IBUPROFEN (88)
DICLOFENAC (85)
ERENUMAB-AOOE (82)
Which DUPILUMAB Alternatives Have Lower Therapeutic product effect delayed Risk?
DUPILUMAB vs DURAGESIC
DUPILUMAB vs DUROGESIC
DUPILUMAB vs DUROTEP MT
DUPILUMAB vs DURVALUMAB
DUPILUMAB vs DUTASTERIDE